BG104292A - Methods and compositions for the treatment of rheumatoid arthritis - Google Patents

Methods and compositions for the treatment of rheumatoid arthritis

Info

Publication number
BG104292A
BG104292A BG104292A BG10429200A BG104292A BG 104292 A BG104292 A BG 104292A BG 104292 A BG104292 A BG 104292A BG 10429200 A BG10429200 A BG 10429200A BG 104292 A BG104292 A BG 104292A
Authority
BG
Bulgaria
Prior art keywords
methods
rheumatoid arthritis
compositions
treatment
medicametous
Prior art date
Application number
BG104292A
Other languages
Bulgarian (bg)
English (en)
Inventor
Teresa Barlozzari
Subhashis Banerjee
Andreas Haupt
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of BG104292A publication Critical patent/BG104292A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BG104292A 1997-10-06 2000-04-03 Methods and compositions for the treatment of rheumatoid arthritis BG104292A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/944,479 US6015790A (en) 1997-10-06 1997-10-06 Methods and compositions for treating rheumatoid arthritis
PCT/US1998/019841 WO1999017792A1 (en) 1997-10-06 1998-09-24 Methods and compositions for treating rheumatoid arthritis

Publications (1)

Publication Number Publication Date
BG104292A true BG104292A (en) 2000-12-29

Family

ID=25481479

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104292A BG104292A (en) 1997-10-06 2000-04-03 Methods and compositions for the treatment of rheumatoid arthritis

Country Status (24)

Country Link
US (1) US6015790A (de)
EP (1) EP1021200B1 (de)
JP (1) JP2001518515A (de)
KR (1) KR20010081900A (de)
CN (1) CN1278734A (de)
AR (1) AR017298A1 (de)
AT (1) ATE212855T1 (de)
AU (2) AU748465B2 (de)
BG (1) BG104292A (de)
BR (1) BR9812875A (de)
CA (1) CA2305688A1 (de)
DE (1) DE69803792D1 (de)
DK (1) DK1021200T3 (de)
ES (1) ES2173626T3 (de)
HR (1) HRP20000265A2 (de)
HU (1) HUP0101715A3 (de)
IL (1) IL135167A0 (de)
NO (1) NO20001758L (de)
PL (1) PL339731A1 (de)
PT (1) PT1021200E (de)
SK (1) SK4272000A3 (de)
TR (1) TR200000903T2 (de)
WO (2) WO1999017792A1 (de)
ZA (1) ZA989036B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010009901A1 (en) * 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
KR100261114B1 (ko) * 1998-01-24 2000-07-01 박종헌 히스톤을 함유하는 류마티스 관절염 치료제 조성물
EP1214087A1 (de) * 1999-09-14 2002-06-19 Pfizer Products Inc. Behandlung mit kombinationen aus il1-ra und diarylsulfonylureaverbindungen
WO2001041789A1 (fr) * 1999-12-07 2001-06-14 Santen Pharmaceutical Co., Ltd. Medicament contre les rhumatismes contenant un derive tetrapeptidique en tant qu'ingredient actif
AU783145B2 (en) 1999-12-24 2005-09-29 F. Hoffmann-La Roche Ag Nitrile derivatives as cathepsin K inhibitors
MX2009007395A (es) * 2007-01-09 2009-07-17 Bayer Schering Pharma Ag Marcacion radioactiva por fluoracion de aziridinas.
US8748370B2 (en) 2009-06-18 2014-06-10 Strongbone Ab Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
RU2655604C2 (ru) * 2013-01-11 2018-05-29 Фуджифилм Корпорэйшн Азотсодержащее гетероциклическое соединение или его соль
KR102372512B1 (ko) * 2017-11-20 2022-03-10 가톨릭대학교 산학협력단 폴리감마글루탐산 및 메토트렉세이트를 유효성분으로 포함하는 관절염 예방 또는 치료용 조성물
CN115281149A (zh) * 2021-05-12 2022-11-04 四川大学华西医院 一种临床前类风湿关节炎(Pre-RA)小鼠模型

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816444A (en) * 1987-07-10 1989-03-28 Arizona Board Of Regents, Arizona State University Cell growth inhibitory substance
US4879278A (en) * 1989-05-16 1989-11-07 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 15
DE69232552T2 (de) * 1991-08-09 2002-10-31 Teikoku Hormone Mfg. Co., Ltd. Tetrapeptide Derivat
US5831002A (en) * 1992-05-20 1998-11-03 Basf Aktiengesellschaft Antitumor peptides
DE69329425T2 (de) * 1992-12-16 2001-01-18 Basf Ag Dolastatin analog
US5504191A (en) * 1994-08-01 1996-04-02 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory pentapeptide methyl esters
US5530097A (en) * 1994-08-01 1996-06-25 Arizona Board Of Regents Acting On Behalf Of Arizona State University Human cancer inhibitory peptide amides
US5583153A (en) * 1994-10-06 1996-12-10 Regents Of The University Of California Use of taxol in the treatment of rheumatoid arthritis

Also Published As

Publication number Publication date
KR20010081900A (ko) 2001-08-29
US6015790A (en) 2000-01-18
DK1021200T3 (da) 2002-05-27
PL339731A1 (en) 2001-01-02
JP2001518515A (ja) 2001-10-16
AU9502498A (en) 1999-04-27
NO20001758D0 (no) 2000-04-05
ATE212855T1 (de) 2002-02-15
AU748465B2 (en) 2002-06-06
HUP0101715A3 (en) 2001-12-28
DE69803792D1 (de) 2002-03-21
SK4272000A3 (en) 2001-02-12
CA2305688A1 (en) 1999-04-15
IL135167A0 (en) 2001-05-20
WO1999017792A1 (en) 1999-04-15
EP1021200A1 (de) 2000-07-26
NO20001758L (no) 2000-06-05
EP1021200B1 (de) 2002-02-06
ZA989036B (en) 2000-04-05
AU9592698A (en) 1999-04-27
PT1021200E (pt) 2002-07-31
ES2173626T3 (es) 2002-10-16
WO1999017709A2 (en) 1999-04-15
TR200000903T2 (tr) 2001-07-23
CN1278734A (zh) 2001-01-03
AR017298A1 (es) 2001-09-05
HRP20000265A2 (en) 2000-12-31
HUP0101715A2 (hu) 2001-11-28
BR9812875A (pt) 2000-08-08

Similar Documents

Publication Publication Date Title
BG103485A (en) Ketobanzamides as calpain inhibitors
MY113806A (en) Antiparasitic marcfortines and paraherquamides
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
MX9709240A (es) Fenilpiridazinonas.
CA2160137A1 (en) Bicyclic Ansamycins
AU3115395A (en) Dihydrobenzofuranes
DK0768997T3 (da) Polyalkoxyterpenderivater og sammensætninger indeholdende disse
IL109720A (en) N-alkylthio polyamine derivatives and radioprotective compositions containing them
IL129592A0 (en) 5-HT1f agonists
MX9804588A (es) Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel.
MY122278A (en) 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
BG101892A (en) Sugar-modified cytostatics
GB9300048D0 (en) Endothelin converting enzyme inhibitors
ZA983704B (en) Phosphodiesterase 4-inhibiting diazepinoindolones.
IL117209A0 (en) 1-aryl-2-acylamino-ethane compounds and pharmaceutical compositions containing them
BG104292A (en) Methods and compositions for the treatment of rheumatoid arthritis
AP9400632A0 (en) Ether derivatives.
BG100248A (bg) Инхибитори на скваленсинтетаза
AU6849198A (en) Neurotrypsin
BG104373A (en) Polymorphous forms of dofetilide
BG103650A (en) Method for the preparation of eprosartan
YU18399A (sh) Postupak alkilacije zaštićenih sulfonamida
DE69929802D1 (en) Lta4 hydrolase-hemmer
BR9407232A (pt) Compostos de tiocarbamoíla